Annual Drug Patent Expirations for GATTEX+KIT
Gattex Kit is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for GATTEX KIT.
The generic ingredient in GATTEX KIT is teduglutide recombinant. One supplier is listed for this compound. Additional details are available on the teduglutide recombinant profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
